Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 9 studies | 27% ± 13% | |
| intestine | 8 studies | 22% ± 6% | |
| prostate | 4 studies | 22% ± 5% | |
| brain | 4 studies | 19% ± 2% | |
| pancreas | 3 studies | 22% ± 2% | |
| peripheral blood | 3 studies | 22% ± 2% | |
| placenta | 3 studies | 18% ± 2% | |
| breast | 3 studies | 17% ± 2% | |
| liver | 3 studies | 25% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4406.16 | 245 / 245 | 100% | 85.83 | 502 / 502 |
| esophagus | 100% | 1270.49 | 1444 / 1445 | 100% | 19.27 | 183 / 183 |
| breast | 100% | 1510.16 | 459 / 459 | 100% | 33.55 | 1117 / 1118 |
| lung | 100% | 1904.79 | 578 / 578 | 100% | 21.26 | 1153 / 1155 |
| intestine | 100% | 3144.75 | 966 / 966 | 100% | 41.03 | 526 / 527 |
| uterus | 100% | 1210.92 | 170 / 170 | 100% | 26.23 | 458 / 459 |
| stomach | 100% | 2119.50 | 359 / 359 | 100% | 34.03 | 285 / 286 |
| skin | 100% | 1588.09 | 1807 / 1809 | 100% | 27.67 | 470 / 472 |
| pancreas | 100% | 1415.78 | 328 / 328 | 99% | 23.40 | 177 / 178 |
| ovary | 100% | 1016.39 | 180 / 180 | 99% | 14.65 | 426 / 430 |
| thymus | 100% | 1179.04 | 652 / 653 | 98% | 14.76 | 595 / 605 |
| bladder | 100% | 1268.10 | 21 / 21 | 98% | 26.04 | 492 / 504 |
| adrenal gland | 100% | 1048.57 | 258 / 258 | 96% | 16.74 | 220 / 230 |
| brain | 97% | 790.91 | 2566 / 2642 | 98% | 13.10 | 692 / 705 |
| liver | 100% | 1459.36 | 226 / 226 | 95% | 12.66 | 386 / 406 |
| kidney | 100% | 1138.37 | 89 / 89 | 95% | 12.55 | 855 / 901 |
| adipose | 100% | 1396.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 37.70 | 29 / 29 |
| spleen | 100% | 2251.02 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 24.06 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 23.27 | 1 / 1 |
| blood vessel | 100% | 1259.43 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 26.79 | 79 / 80 |
| peripheral blood | 98% | 1587.94 | 915 / 929 | 0% | 0 | 0 / 0 |
| muscle | 95% | 747.85 | 765 / 803 | 0% | 0 | 0 / 0 |
| heart | 95% | 1017.72 | 817 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006055 | Biological process | CMP-N-acetylneuraminate biosynthetic process |
| GO_0016051 | Biological process | carbohydrate biosynthetic process |
| GO_0070085 | Biological process | glycosylation |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008781 | Molecular function | N-acylneuraminate cytidylyltransferase activity |
| GO_0050462 | Molecular function | N-acetylneuraminate synthase activity |
| GO_0047444 | Molecular function | N-acylneuraminate-9-phosphate synthase activity |
| Gene name | NANS |
| Protein name | N-acetylneuraminate synthase Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) |
| Synonyms | SAS |
| Description | FUNCTION: Produces N-acetylneuraminic acid (Neu5Ac) and 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN) . Can also use N-acetylmannosamine 6-phosphate and mannose 6-phosphate as substrates to generate phosphorylated forms of Neu5Ac and KDN, respectively . . |
| Accessions | Q5TBR0 Q9NR45 ENST00000427646.1 ENST00000415280.1 ENST00000210444.6 Q5TBR1 |